Hyperfine, Inc. (HYPR) News
Filter HYPR News Items
HYPR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest HYPR News From Around the Web
Below are the latest news stories about HYPERFINE INC that investors may wish to consider to help them evaluate HYPR as an investment opportunity.
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023GUILFORD, Conn., November 20, 2023--Hyperfine, Inc. announces presentations on clinical advancements at RSNA 2023 |
Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare ConferenceGUILFORD, Conn., November 16, 2023--Hyperfine, Inc. to present at the Piper Sandler 35th annual healthcare conference. |
Hyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call TranscriptHyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call Transcript November 10, 2023 Operator: Good afternoon, and welcome to Hyperfine’s Third Quarter 2023 Earnings Conference Call. Currently, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today’s call. As a reminder, this call is being recorded for replay […] |
Hyperfine, Inc. Reports Third Quarter 2023 Financial ResultsGUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced third quarter 2023 financial results and provided a business update. “We remain focused on our three strategic pillars of innovation, clinical evidence, and commercialization, all while actively managing o |
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO PatientsGUILFORD, Conn., November 02, 2023--Observational study finds that Hyperfine, Inc. portable MR brain imaging system assists clinicians in early detection of ABI in ECMO patients |
Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023GUILFORD, Conn., October 19, 2023--Hyperfine, Inc. to announce third quarter financial results on November 9, 2023 |
Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs ExecutivesGUILFORD, Conn., October 10, 2023--Hyperfine, Inc. announces promotions of two key clinical affairs executives |
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System SequencesGUILFORD, Conn., October 09, 2023--Hyperfine, Inc. receives FDA clearance for updated AI-powered software with improved image quality for all Swoop® system sequences |
Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth ShowcaseGUILFORD, Conn., September 07, 2023--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually. Members of management are scheduled to present on Thursday, September 21, 2023, at 1:00 pm ET. |
Hyperfine, Inc. Reports Second Quarter 2023 Financial ResultsGUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced second quarter 2023 financial results and provided a business update. “We made solid progress at Hyperfine in the second quarter of 2023 and delivered record revenue of over $3.3 million. We remained focused on our three strategic pillars of innovation, clinica |